Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Clinical trial NCT04006847 · TERMINATED
Trial details
- NCT number
- NCT04006847
- Sponsor
- Milton S. Hershey Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2021-05-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.